Drug Type Small molecule drug |
Synonyms- |
Target |
Action inhibitors, modulators |
Mechanism NF-κB inhibitors(Nuclear factor NF-kappa-B complex inhibitors), TNF modulators(Tumor necrosis factor modulators), TNF-α inhibitors(Tumor necrosis factor α inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Anemia | Discovery | - | 12 Mar 2026 | |
| Cardiovascular Diseases | Discovery | - | 12 Mar 2026 | |
| Colitis | Discovery | - | 12 Mar 2026 | |
| Endocrinology and Metabolic Disease | Discovery | - | 12 Mar 2026 | |
| Eye Diseases | Discovery | - | 12 Mar 2026 | |
| Immune System Diseases | Discovery | - | 12 Mar 2026 | |
| Infectious Diseases | Discovery | - | 12 Mar 2026 | |
| Neoplasms | Discovery | - | 12 Mar 2026 | |
| Neurodegenerative Diseases | Discovery | - | 12 Mar 2026 | |
| Other Diseases | Discovery | - | 12 Mar 2026 |





